Biotech Values

[DewDiligence]

WPI (Amphastar’s putative partner on generic Lovenox) is holding an Investor Day webcast on 1/21/11:

http://finance.yahoo.com/news/Watson-to-Host-Investor-Day-prnews-2573768879.html?x=0&.v=1

Given the noise Amphastar has been making about alleged mistreatment by the FDA with respect to its Lovenox ANDA, one might think WPI would have chimed in at least once to express an opinion. They have not done so, however, which leads me to believe that WPI considers the Lovenox ANDA to be dead as a doorknob.